Table 3 from Gedatolisib Combined with Palbociclib and Letrozole in Patients with No Prior Systemic Therapy for Hormone Receptor–Positive, HER2-Negative Advanced Breast Cancer
收藏NIAID Data Ecosystem2026-05-10 收录
数据链接：
官方服务：
资源简介：
TEAEs (of any cause, occurring in >20% of patients in the safety analysis set; N = 41).
创建时间：
2025-10-01
